"Middle Aged" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
No definition found.
| Descriptor ID |
D008875
|
| MeSH Number(s) |
M01.060.116.630
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Middle Aged".
Below are MeSH descriptors whose meaning is more specific than "Middle Aged".
This graph shows the total number of publications written about "Middle Aged" by people in this website by year, and whether "Middle Aged" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1996 | 0 | 185 | 185 |
| 1997 | 0 | 215 | 215 |
| 1998 | 0 | 212 | 212 |
| 1999 | 0 | 244 | 244 |
| 2000 | 0 | 263 | 263 |
| 2001 | 0 | 335 | 335 |
| 2002 | 0 | 355 | 355 |
| 2003 | 0 | 459 | 459 |
| 2004 | 0 | 480 | 480 |
| 2005 | 0 | 512 | 512 |
| 2006 | 0 | 515 | 515 |
| 2007 | 0 | 558 | 558 |
| 2008 | 0 | 602 | 602 |
| 2009 | 0 | 682 | 682 |
| 2010 | 0 | 711 | 711 |
| 2011 | 0 | 802 | 802 |
| 2012 | 0 | 922 | 922 |
| 2013 | 0 | 1052 | 1052 |
| 2014 | 0 | 1000 | 1000 |
| 2015 | 0 | 1103 | 1103 |
| 2016 | 0 | 1144 | 1144 |
| 2017 | 0 | 1240 | 1240 |
| 2018 | 0 | 1279 | 1279 |
| 2019 | 0 | 1196 | 1196 |
| 2020 | 0 | 1097 | 1097 |
| 2021 | 0 | 770 | 770 |
| 2022 | 0 | 295 | 295 |
| 2023 | 0 | 260 | 260 |
| 2024 | 0 | 1162 | 1162 |
| 2025 | 0 | 960 | 960 |
| 2026 | 0 | 4 | 4 |
To return to the timeline,
click here.
Below are the most recent publications written about "Middle Aged" by people in Profiles.
-
New comorbidity index associated with survival after chimeric antigen receptor T-cell therapy for large B-cell lymphoma. Blood Adv. 2026 Jan 13; 10(1):217-227.
-
Validating and leveraging non-SARS-CoV-2 respiratory infection as a negative control outcome in a phase 3 COVID-19 vaccine trial with extended observational follow-up. Am J Epidemiol. 2026 Jan 08; 195(1):168-177.
-
ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR THERAPY FOR STAGES 3 AND 4 PROLIFERATIVE SICKLE CELL RETINOPATHY RESULTS IN IMPROVED ANATOMICAL AND VISUAL OUTCOMES. Retina. 2026 Jan 01; 46(1):171-178.
-
Performance of Ulcer Features in Predicting Malignancy Among Gastric Ulcers Diagnosed on Upper Endoscopy. J Clin Gastroenterol. 2026 Jan 01; 60(1):40-46.
-
Liberal or Restrictive Postoperative Transfusion in Patients at High Cardiac Risk: The TOP Randomized Clinical Trial. JAMA. 2025 Dec 23; 334(24):2197-2207.
-
Outcomes after transition from ibrutinib to zanubrutinib in patients with Waldenstr?m macroglobulinemia from the ASPEN study. Blood Adv. 2025 Dec 23; 9(24):6538-6546.
-
Clinical and Genomic Characterization of Recalcitrant Enterococcal Bacteremia: A Multicenter Prospective Cohort Study (VENOUS). J Infect Dis. 2025 Dec 20; 232(6):1351-1364.
-
Using Machine Learning Algorithms to Identify Key Predictors of Invasive Mold Infection Surveillance. J Infect Dis. 2025 Dec 20; 232(6):e1033-e1042.
-
Incidence and Management of Adverse Events Associated with Tebentafusp Treatment in Metastatic Uveal Melanoma: Pooled Safety Analysis of 410 Patients. Clin Cancer Res. 2025 Dec 01; 31(23):5027-5036.
-
Associations between 6-minute walk distance and physiologic measures and clinical outcomes in myositis-associated interstitial lung disease. Rheumatology (Oxford). 2025 Dec 01; 64(SI):SI79-SI87.